Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Dermatomyositis × Etanercept × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Arthritis, Rheumatoid 8 Psoriasis 7 Lymphoma, Follicular 4 Leukemia 4 Myelodysplastic Syndromes 3 Asthma 3 Vasculitis 2 Respiratory Distress Syndrome 2 Recurrence 2 Pneumonia 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 2 Inflammation 2 Granulomatosis with Polyangiitis 2 Bronchiolitis Obliterans 2 Arthritis, Psoriatic 2 Arthritis, Juvenile 2 Wilms Tumor 1 Uveitis 1 Temporomandibular Joint Disorders 1 Spondylitis, Ankylosing 1 Spondylarthritis 1 Pruritus 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Plaque, Amyloid 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasms 1 Metabolic Syndrome 1

Interventions

Sodium Chloride 1 Etanercept 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00112385 2011-06-21

A Pilot Study of Etanercept in Dermatomyositis

Brigham and Women's Hospital

Phase 1 Completed

16 enrolled 42 charts

Dermatomyositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡